Curcumin boosts DHA in the brain: Implications for the prevention of anxiety disorders

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 5, 2015, Pages 951-961

  Wu, Aiguo ^a   Noble, Emily E ^a   Tyagi, Ethika ^a   Ying, Zhe ^a   Zhuang, Yumei ^a   Gomez Pinilla, Fernando ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ALA; Curcumin; DHA synthesis; Docosahexaenoic acid; DPA; Omega 3 fatty acid

Indexed keywords

CURCUMIN; DOCOSAHEXAENOIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; ACYL COENZYME A DESATURASE; ACYLTRANSFERASE; FATTY ACID ELONGASES; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN PROTECTION; COGNITION; CONTROLLED STUDY; DIET; HEPG2 CELL LINE; HIPPOCAMPUS; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; LIPID ANALYSIS; LIPID DEGRADATION; LIPID PEROXIDATION; MALE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ANXIETY DISORDERS; BRAIN; DIETARY SUPPLEMENT; DRUG EFFECTS; DRUG POTENTIATION; HUMAN; LIVER; MAZE TEST; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

CURCUMA LONGA; RODENTIA;

ACETYLTRANSFERASES; ALPHA-LINOLENIC ACID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANXIETY DISORDERS; BRAIN; CURCUMIN; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DRUG SYNERGISM; FATTY ACID DESATURASES; HEP G2 CELLS; HUMANS; IMMUNOBLOTTING; LIVER; MALE; MAZE LEARNING; RATS, SPRAGUE-DAWLEY;

EID: 84922576124     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.12.005     Document Type: Article

References (110)

1. Chen H.F., Su H.M. Exposure to a maternal n-3 fatty acid-deficient diet during brain development provokes excessive hypothalamic-pituitary-adrenal axis responses to stress and behavioral indices of depression and anxiety in male rat offspring later in life. J. Nutr. Biochem. 2013, 24:70-80.
2. Bhatia H.S., Agrawal R., Sharma S., Huo Y.X., Ying Z., Gomez-Pinilla F. Omega-3 fatty acid deficiency during brain maturation reduces neuronal and behavioral plasticity in adulthood. PLoS ONE 2011, 6:e28451.
3. Astarita G., Jung K.M., Berchtold N.C., Nguyen V.Q., Gillen D.L., Head E., Cotman C.W., Piomelli D. Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PLoS ONE 2010, 5:e12538.
4. Liu J.J., Galfalvy H.C., Cooper T.B., Oquendo M.A., Grunebaum M.F., Mann J.J., Sublette M.E. Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders. J. Clin. Psychiatry 2013, 74:732-738.
5. McNamara R.K., Jandacek R., Rider T., Tso P., Dwivedi Y., Pandey G.N. Adult medication-free schizophrenic patients exhibit long-chain omega-3 fatty acid deficiency: implications for cardiovascular disease risk. Cardiovasc. Psychiatry Neurol. 2013, 2013:796462.
6. Sethom M.M., Fares S., Bouaziz N., Melki W., Jemaa R., Feki M., Hechmi Z., Kaabachi N. Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia. Prostaglandins Leukot. Essent. Fat. Acids 2010, 83:131-136.
7. Colombo J., Kannass K.N., Shaddy D.J., Kundurthi S., Maikranz J.M., Anderson C.J., Blaga O.M., Carlson S.E. Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev. 2004, 75:1254-1267.
8. Kannass K.N., Colombo J., Carlson S.E. Maternal DHA levels and toddler free-play attention. Dev. Neuropsychol. 2009, 34:159-174.
9. Xiao Y., Wang L., Xu R.J., Chen Z.Y. DHA depletion in rat brain is associated with impairment on spatial learning and memory. Biomed. Environ. Sci. 2006, 19:474-480.
10. Fedorova I., Hussein N., Baumann M.H., Di Martino C., Salem N. An n-3 fatty acid deficiency impairs rat spatial learning in the Barnes maze. Behav. Neurosci. 2009, 123:196-205.
11. Fedorova I., Hussein N., Di Martino C., Moriguchi T., Hoshiba J., Majchrzak S., Salem N. An n-3 fatty acid deficient diet affects mouse spatial learning in the Barnes circular maze. Prostaglandins Leukot. Essent. Fat. Acids 2007, 77:269-277.
12. Bach S.A., de Siqueira L.V., Muller A.P., Oses J.P., Quatrim A., Emanuelli T., Vinade L., Souza D.O., Moreira J.D. Dietary omega-3 deficiency reduces BDNF content and activation NMDA receptor and Fyn in dorsal hippocampus: implications on persistence of long-term memory in rats. Nutr. Neurosci. 2014, 17:186-192.
13. Anderson G.J., Connor W.E., Corliss J.D. Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina. Pediatr. Res. 1990, 27:89-97.
14. Neuringer M., Anderson G.J., Connor W.E. The essentiality of n-3 fatty acids for the development and function of the retina and brain. Annu. Rev. Nutr. 1988, 8:517-541.
15. O'Brien J.S., Sampson E.L. Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin. J. Lipid Res. 1965, 6:545-551.
16. Svennerholm L. Distribution and fatty acid composition of phosphoglycerides in normal human brain. J. Lipid Res. 1968, 9:570-579.
17. Brenna J.T., Carlson S.E. Docosahexaenoic acid and human brain development: evidence that a dietary supply is needed for optimal development. J. Hum. Evol. 2014, 77:99-106.
18. Gamoh S., Hashimoto M., Hossain S., Masumura S. Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Clin. Exp. Pharmacol. Physiol. 2001, 28:266-270.
19. Lim G.P., Chu T., Yang F., Beech W., Frautschy S.A., Cole G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 2001, 21:8370-8377.
20. Sugimoto Y., Taga C., Nishiga M., Fujiwara M., Konishi F., Tanaka K., Kamei C. Effect of docosahexaenoic acid-fortified Chlorella vulgaris strain CK22 on the radial maze performance in aged mice. Biol. Pharm. Bull. 2002, 25:1090-1092.
21. Whalley L.J., Starr J.M., Deary I.J. Diet and dementia. J. Br. Menopausal Soc. 2004, 10:113-117.
22. Wu A., Ying Z., Gomez-Pinilla F. Dietary strategy to repair plasma membrane after brain trauma: implications for plasticity and cognition. Neurorehabil. Neural Repair 2014, 28:75-84.
23. Desai A., Kevala K., Kim H.Y. Depletion of brain docosahexaenoic acid impairs recovery from traumatic brain injury. PLoS ONE 2014, 9:e86472.
24. Perez M.A., Terreros G., Dagnino-Subiabre A. Long-term omega-3 fatty acid supplementation induces anti-stress effects and improves learning in rats. Behav. Brain Funct. 2013, 9:25.
25. Buydens-Branchey L., Branchey M. n-3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J. Clin. Psychopharmacol. 2006, 26:661-665.
26. Buydens-Branchey L., Branchey M., Hibbeln J.R. Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2008, 32:568-575.
27. Chen H.F., Su H.M. Fish oil supplementation of maternal rats on an n-3 fatty acid-deficient diet prevents depletion of maternal brain regional docosahexaenoic acid levels and has a postpartum anxiolytic effect. J. Nutr. Biochem. 2012, 23:299-305.
28. Smink W., Gerrits W.J., Gloaguen M., Ruiter A., van Baal J. Linoleic and alpha-linolenic acid as precursor and inhibitor for the synthesis of long-chain polyunsaturated fatty acids in liver and brain of growing pigs. Anim. Int. J. Anim. Biosci. 2012, 6:262-270.
29. Igarashi M., DeMar J.C., Ma K., Chang L., Bell J.M., Rapoport S.I. Docosahexaenoic acid synthesis from alpha-linolenic acid by rat brain is unaffected by dietary n-3 PUFA deprivation. J. Lipid Res. 2007, 48:1150-1158.
30. Kidd P.M. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. J. Clin. Ther. 2007, 12:207-227.
31. Plourde M., Cunnane S.C. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Physiol. Appl. Nutr. Metab. 2007, 32:619-634.
32. Brenna J.T., Salem N., Sinclair A.J., Cunnane S.C., International Society for the Study of Fatty and Lipids Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot. Essent. Fat. Acids 2009, 80:85-91.
33. Kornsteiner M., Singer I., Elmadfa I. Very low n-3 long-chain polyunsaturated fatty acid status in Austrian vegetarians and vegans. Ann. Nutr. Metab. 2008, 52:37-47.
34. Mann N., Pirotta Y., O'Connell S., Li D., Kelly F., Sinclair A. Fatty acid composition of habitual omnivore and vegetarian diets. Lipids 2006, 41:637-646.
35. Rosell M.S., Lloyd-Wright Z., Appleby P.N., Sanders T.A., Allen N.E., Key T.J. Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men. Am. J. Clin. Nutr. 2005, 82:327-334.
36. Sanders T.A. DHA status of vegetarians. Prostaglandins Leukot. Essent. Fat. Acids 2009, 81:137-141.
37. Begum A.N., Jones M.R., Lim G.P., Morihara T., Kim P., Heath D.D., Rock C.L., Pruitt M.A., Yang F., Hudspeth B., Hu S., Faull K.F., Teter B., Cole G.M., Frautschy S.A. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J. Pharmacol. Exp. Ther. 2008, 326:196-208.
38. Yang F., Lim G.P., Begum A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P.P., Kayed R., Glabe C.G., Frautschy S.A., Cole G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005, 280:5892-5901.
39. Wang Y., Yin H., Wang L., Shuboy A., Lou J., Han B., Zhang X., Li J. Curcumin as a potential treatment for Alzheimer's disease: a study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein. Am. J. Chin. Med. 2013, 41:59-70.
40. Thiyagarajan M., Sharma S.S. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 2004, 74:969-985.
41. Wu A., Ying Z., Gomez-Pinilla F. Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp. Neurol. 2006, 197:309-317.
42. Sharma S., Zhuang Y., Ying Z., Wu A., Gomez-Pinilla F. Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma. Neuroscience 2009, 161:1037-1044.
43. Samini F., Samarghandian S., Borji A., Mohammadi G., bakaian M. Curcumin pretreatment attenuates brain lesion size and improves neurological function following traumatic brain injury in the rat. Pharmacol. Biochem. Behav. 2013, 110:238-244.
44. Gupta S.K., Kumar B., Nag T.C., Agrawal S.S., Agrawal R., Agrawal P., Saxena R., Srivastava S. Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J. Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther. 2011, 27:123-130.
45. Ueki M., Ueno M., Morishita J., Maekawa N. Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice. J. Biosci. Bioeng. 2013, 115:547-551.
46. Kawanishi N., Kato K., Takahashi M., Mizokami T., Otsuka Y., Imaizumi A., Shiva D., Yano H., Suzuki K. Curcumin attenuates oxidative stress following downhill running-induced muscle damage. Biochem. Biophys. Res. Commun. 2013, 441:573-578.
47. Zhao W.C., Zhang B., Liao M.J., Zhang W.X., He W.Y., Wang H.B., Yang C.X. Curcumin ameliorated diabetic neuropathy partially by inhibition of NADPH oxidase mediating oxidative stress in the spinal cord. Neurosci. Lett. 2014, 560:81-85.
48. Soetikno V., Sari F.R., Lakshmanan A.P., Arumugam S., Harima M., Suzuki K., Kawachi H., Watanabe K. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway. Mol. Nutr. Food Res. 2013, 57:1649-1659.
49. Gao S., Duan X., Wang X., Dong D., Liu D., Li X., Sun G., Li B. Curcumin attenuates arsenic-induced hepatic injuries and oxidative stress in experimental mice through activation of Nrf2 pathway, promotion of arsenic methylation and urinary excretion. Food Chem. Toxicol. 2013, 59:739-747.
50. Mei X.T., Xu D.H., Xu S.K., Zheng Y.P., Xu S.B. Zinc(II)-curcumin accelerates the healing of acetic acid-induced chronic gastric ulcers in rats by decreasing oxidative stress and downregulation of matrix metalloproteinase-9. Food Chem. Toxicol. 2013, 60:448-454.
51. Walf A.A., Frye C.A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2007, 2:322-328.
52. Portolesi R., Powell B.C., Gibson R.A. Competition between 24:5n-3 and ALA for delta 6 desaturase may limit the accumulation of DHA in HepG2 cell membranes. J. Lipid Res. 2007, 48:1592-1598.
53. Garcia-Calatayud S., Redondo C., Martin E., Ruiz J.I., Garcia-Fuentes M., Sanjurjo P. Brain docosahexaenoic acid status and learning in young rats submitted to dietary long-chain polyunsaturated fatty acid deficiency and supplementation limited to lactation. Pediatr. Res. 2005, 57:719-723.
54. Lim S.Y., Hoshiba J., Moriguchi T., Salem N. N-3 fatty acid deficiency induced by a modified artificial rearing method leads to poorer performance in spatial learning tasks. Pediatr. Res. 2005, 58:741-748.
55. Moriguchi T., Salem N. Recovery of brain docosahexaenoate leads to recovery of spatial task performance. J. Neurochem. 2003, 87:297-309.
56. Greiner R.S., Moriguchi T., Slotnick B.M., Hutton A., Salem N. Olfactory discrimination deficits in n-3 fatty acid-deficient rats. Physiol. Behav. 2001, 72:379-385.
57. Moriguchi T., Greiner R.S., Salem N. Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J. Neurochem. 2000, 75:2563-2573.
58. Lim S.Y., Suzuki H. Effect of dietary docosahexaenoic acid and phosphatidylcholine on maze behavior and fatty acid composition of plasma and brain lipids in mice. Int. J. Vitam. Nutr. Res. 2000, 70:251-259.
59. Lim S.Y., Suzuki H. Intakes of dietary docosahexaenoic acid ethyl ester and egg phosphatidylcholine improve maze-learning ability in young and old mice. J. Nutr. 2000, 130:1629-1632.
60. Minami M., Kimura S., Endo T., Hamaue N., Hirafuji M., Togashi H., Matsumoto M., Yoshioka M., Saito H., Watanabe S., Kobayashi T., Okuyama H. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol. Biochem. Behav. 1997, 58:1123-1129.
61. Chytrova G., Ying Z., Gomez-Pinilla F. Exercise contributes to the effects of DHA dietary supplementation by acting on membrane-related synaptic systems. Brain Res. 2010, 1341:32-40.
62. Gamoh S., Hashimoto M., Sugioka K., Shahdat Hossain M., Hata N., Misawa Y., Masumura S. Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats. Neuroscience 1999, 93:237-241.
63. Whalley L.J., Fox H.C., Wahle K.W., Starr J.M., Deary I.J. Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am. J. Clin. Nutr. 2004, 80:1650-1657.
64. Heude B., Ducimetiere P., Berr C., Study E.V.A. Cognitive decline and fatty acid composition of erythrocyte membranes-the EVA study. Am. J. Clin. Nutr. 2003, 77:803-808.
65. Key T.J., Appleby P.N., Rosell M.S. Health effects of vegetarian and vegan diets. Proc. Nutr. Soc. 2006, 65:35-41.
66. Welch A.A., Shakya-Shrestha S., Lentjes M.A., Wareham N.J., Khaw K.T. Dietary intake and status of n-3 polyunsaturated fatty acids in a population of fish-eating and non-fish-eating meat-eaters, vegetarians, and vegans and the product-precursor ratio [corrected] of alpha-linolenic acid to long-chain n-3 polyunsaturated fatty acids: results from the EPIC-Norfolk cohort. Am. J. Clin. Nutr. 2010, 92:1040-1051.
67. Blasbalg T.L., Hibbeln J.R., Ramsden C.E., Majchrzak S.F., Rawlings R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr. 2011, 93:950-962.
68. FAO The State of World Fisheries and Aquaculture, in, Rome 2012, 209.
69. Crampton V.O., Nanton D.A., Ruohonen K., Skjervold P.O., El-Mowafi A. Demonstration of salmon farming as a net producer of fish protein and oil. Aquacult. Nutr. 2010, 16:437-446.
70. Gu J.N., Krogdahl A., Sissener N.H., Kortner T.M., Gelencser E., Hemre G.I., Bakke A.M. Effects of oral Bt-maize (MON810) exposure on growth and health parameters in normal and sensitised Atlantic salmon, Salmo salar L. Br. J. Nutr. 2013, 109:1408-1423.
71. Turchini G.M., Francis D.S. Fatty acid metabolism (desaturation, elongation and beta-oxidation) in rainbow trout fed fish oil- or linseed oil-based diets. Br. J. Nutr. 2009, 102:69-81.
72. Bell J.G., Tocher D.R., Henderson R.J., Dick J.R., Crampton V.O. Altered fatty acid compositions in Atlantic salmon (Salmo salar) fed diets containing linseed and rapeseed oils can be partially restored by a subsequent fish oil finishing diet. J. Nutr. 2003, 133:2793-2801.
73. Menoyo D., Lopez-Bote C.J., Obach A., Bautista J.M. Effect of dietary fish oil substitution with linseed oil on the performance, tissue fatty acid profile, metabolism, and oxidative stability of Atlantic salmon. J. Anim. Sci. 2005, 83:2853-2862.
74. Hixson S.M., Parrish C.C., Anderson D.M. Changes in tissue lipid and fatty acid composition of farmed rainbow trout in response to dietary camelina oil as a replacement of fish oil. Lipids 2014, 49:97-111.
75. Daley C.A., Abbott A., Doyle P.S., Nader G.A., Larson S. A review of fatty acid profiles and antioxidant content in grass-fed and grain-fed beef. Nutr. J. 2010, 9:10.
76. Torde R.G., Therrien A.J., Shortreed M.R., Smith L.M., Lamos S.M. Multiplexed analysis of cage and cage free chicken egg fatty acids using stable isotope labeling and mass spectrometry. Molecules 2013, 18:14977-14988.
77. Reddy S., Sanders T.A., Obeid O. The influence of maternal vegetarian diet on essential fatty acid status of the newborn. Eur. J. Clin. Nutr. 1994, 48:358-368.
78. Beezhold B.L., Johnston C.S., Daigle D.R. Vegetarian diets are associated with healthy mood states: a cross-sectional study in Seventh Day Adventist adults. Nutr. J. 2010, 9:26.
79. Yadav Y., Kumar S. The food habits of a nation. The Hindu 2006.
80. Tapsell L.C., Hemphill I., Cobiac L., Patch C.S., Sullivan D.R., Fenech M., Roodenrys S., Keogh J.B., Clifton P.M., Williams P.G., Fazio V.A., Inge K.E. Health benefits of herbs and spices: the past, the present, the future. Med. J. Aust. 2006, 185:S4-S24.
81. Hutchins-Wolfbrandt A., Mistry A.M. Dietary turmeric potentially reduces the risk of cancer. Asian Pac. J. Cancer Prev. 2011, 12:3169-3173.
82. Cheng K.K., Yeung C.F., Ho S.W., Chow S.F., Chow A.H., Baum L. Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 mice. AAPS J. 2013, 15:324-336.
83. Lazar A.N., Mourtas S., Youssef I., Parizot C., Dauphin A., Delatour B., Antimisiaris S.G., Duyckaerts C. Curcumin-conjugated nanoliposomes with high affinity for Aß deposits: possible applications to Alzheimer disease. Nanomedicine Nanotechnol. Biol. Med. 2013, 9:712-721.
84. Wang L.L., Sun Y., Huang K., Zheng L. Curcumin, a potential therapeutic candidate for retinal diseases. Mol. Nutr. Food Res. 2013, 57:1557-1568.
85. Mirza M., Volz C., Karlstetter M., Langiu M., Somogyi A., Ruonala M.O., Tamm E.R., Jagle H., Langmann T. Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: a beneficial effect of DHA and curcumin supplementation. PLoS ONE 2013, 8:e75963.
86. Mythri R.B., Bharath M.M. Curcumin: a potential neuroprotective agent in Parkinson's disease. Curr. Pharm. Des. 2012, 18:91-99.
87. Jiang T.F., Zhang Y.J., Zhou H.Y., Wang H.M., Tian L.P., Liu J., Ding J.Q., Chen S.D. Curcumin ameliorates the neurodegenerative pathology in A53T alpha-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy. J. NeuroImmune Pharmacol. 2013, 8:356-369.
88. Lapchak P.A. Neuroprotective and neurotrophic curcuminoids to treat stroke: a translational perspective. Expert Opin. Investig. Drug. 2011, 20:13-22.
89. Sanmukhani J., Anovadiya A., Tripathi C.B. Evaluation of antidepressant like activity of curcumin and its combination with fluoxetine and imipramine: an acute and chronic study. Acta Pol. Pharm. 2011, 68:769-775.
90. Sanmukhani J., Satodia V., Trivedi J., Patel T., Tiwari D., Panchal B., Goel A., Tripathi C.B. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother. Res. 2014, 28:579-585.
91. Gomez-Pinilla F., Nguyen T.T. Natural mood foods: the actions of polyphenols against psychiatric and cognitive disorders. Nutr. Neurosci. 2012, 15:127-133.
92. Kaur G., Begg D.P., Barr D., Garg M., Cameron-Smith D., Sinclair A.J. Short-term docosapentaenoic acid (22:5 n-3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentrations in rats. Br. J. Nutr. 2010, 103:32-37.
93. Qiu X. Biosynthesis of docosahexaenoic acid (DHA, 22:6-4, 7,10,13,16,19): two distinct pathways. Prostaglandins Leukot. Essent. Fat. Acids 2003, 68:181-186.
94. Su H.M., Moser A.B., Moser H.W., Watkins P.A. Peroxisomal straight-chain acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis. J. Biol. Chem. 2001, 276:38115-38120.
95. Ferdinandusse S., Denis S., Mooijer P.A., Zhang Z., Reddy J.K., Spector A.A., Wanders R.J. Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. J. Lipid Res. 2001, 42:1987-1995.
96. Talahalli R.R., Vallikannan B., Sambaiah K., Lokesh B.R. Lower efficacy in the utilization of dietary ALA as compared to preformed EPA+DHA on long chain n-3 PUFA levels in rats. Lipids 2010, 45:799-808.
97. Chiu S.S., Lui E., Majeed M., Vishwanatha J.K., Ranjan A.P., Maitra A., Pramanik D., Smith J.A., Helson L. Differential distribution of intravenous curcumin formulations in the rat brain. Anticancer Res. 2011, 31:907-911.
98. Kakkar V., Mishra A.K., Chuttani K., Kaur I.P. Proof of concept studies to confirm the delivery of curcumin loaded solid lipid nanoparticles (C-SLNs) to brain. Int. J. Pharm. 2013, 448:354-359.
99. Gazal M., Valente M.R., Acosta B.A., Kaufmann F.N., Braganhol E., Lencina C.L., Stefanello F.M., Ghisleni G., Kaster M.P. Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats. Eur. J. Pharmacol. 2014, 724:132-139.
100. Rajasekar N., Dwivedi S., Tota S.K., Kamat P.K., Hanif K., Nath C., Shukla R. Neuroprotective effect of curcumin on okadaic acid induced memory impairment in mice. Eur. J. Pharmacol. 2013, 715:381-394.
101. Wu A., Ying Z., Schubert D., Gomez-Pinilla F. Brain and spinal cord interaction: a dietary curcumin derivative counteracts locomotor and cognitive deficits after brain trauma. Neurorehabil. Neural Repair 2011, 25:332-342.
102. Marszalek J.R., Lodish H.F. Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you. Annu. Rev. Cell Dev. Biol. 2005, 21:633-657.
103. Crawford M.A., Bazinet R.P., Sinclair A.J. Fat intake and CNS functioning: ageing and disease. Ann. Nutr. Metab. 2009, 55:202-228.
104. Burdge G.C., Calder P.C. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod. Nutr. Dev. 2005, 45:581-597.
105. Rapoport S.I., Rao J.S., Igarashi M. Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot. Essent. Fat. Acids 2007, 77:251-261.
106. Kim H.Y. Novel metabolism of docosahexaenoic acid in neural cells. J. Biol. Chem. 2007, 282:18661-18665.
107. Rapoport S.I., Igarashi M. Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA?. Prostaglandins Leukot. Essent. Fat. Acids 2009, 81:119-123.
108. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4:807-818.
109. Aggarwal B.B., Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci. 2009, 30:85-94.
110. Araya J., Rodrigo R., Pettinelli P., Araya A.V., Poniachik J., Videla L.A. Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. Obesity 2010, 18:1460-1463.